|
Market Cap (3-Jul) $62,137,976 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (19-Jun) 737,517 (0.45%) (320th) |
|
52w High $1.12 |
52w Low $0.285 |
P/E - |
EPS -0.06 |
PIQ released this announcement to the ASX on 4 February 2022, 8:20. The announcement is marked as price sensitive, and is 10 page(s) in length and 780.78kb in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.000% short sold according to ASIC data. It was ranked the 665th most shorted stock on the ASX. It is now ranked as the 320th most shorted stock on the ASX with 0.451% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| Unique panel of biomarkers identified for oesophageal cancer | 4 February 2022, 8:20 |
| December 2021 Quarterly Activities Report and Appendix 4C | 27 January 2022, 8:14 |
| Change of Registry Address | 20 December 2021, 14:56 |
| Proteomics secures major pharmacokinetic testing contract | 16 December 2021, 8:30 |
You must be logged in to post a reply.
Proteomics International Laboratories 